The push to democratize advanced medical testing, particularly for low-resource and at-home use, just received a significant boost. INTU Diagnostics, a company focused on instrument-free PCR applications, has successfully closed a $1.2M funding round.
This fresh capital will accelerate INTU Diagnostics' mission to make sophisticated diagnostics accessible outside traditional lab settings. By eliminating the need for specialized equipment, the company aims to bring critical health insights directly to individuals and communities that currently lack easy access.
